vs
MACH NATURAL RESOURCES LP（MNR）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是MACH NATURAL RESOURCES LP的1.6倍（$622.0M vs $387.5M），Royalty Pharma plc净利率更高（34.4% vs 18.9%，领先15.6%），MACH NATURAL RESOURCES LP同比增速更快（65.0% vs 4.8%），过去两年MACH NATURAL RESOURCES LP的营收复合增速更高（27.3% vs 4.6%）
Mach Natural Resources LP是一家总部位于美国的上游能源企业，主要从事石油、天然气及液化天然气的勘探、开发与生产业务，核心运营资产分布在二叠纪盆地等美国陆上油气产区，专注于开发低成本高收益资产，为利益相关方创造可持续回报。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MNR vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.6倍
$387.5M
营收增速更快
MNR
高出60.2%
4.8%
净利率更高
RPRX
高出15.6%
18.9%
两年增速更快
MNR
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $387.5M | $622.0M |
| 净利润 | $73.1M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 26.1% | 62.4% |
| 净利率 | 18.9% | 34.4% |
| 营收同比 | 65.0% | 4.8% |
| 净利润同比 | 100.2% | 2.9% |
| 每股收益（稀释后） | $0.47 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MNRRPRX
| Q4 25 | $387.5M | $622.0M | ||
| Q3 25 | $272.6M | $609.3M | ||
| Q2 25 | $288.5M | $578.7M | ||
| Q1 25 | $226.8M | $568.2M | ||
| Q4 24 | $234.9M | $593.6M | ||
| Q3 24 | $255.5M | $564.7M | ||
| Q2 24 | $240.0M | $537.3M | ||
| Q1 24 | $239.2M | $568.0M |
净利润MNRRPRX
| Q4 25 | $73.1M | $214.2M | ||
| Q3 25 | $-35.7M | $288.2M | ||
| Q2 25 | $89.7M | $30.2M | ||
| Q1 25 | $15.9M | $238.3M | ||
| Q4 24 | $36.5M | $208.2M | ||
| Q3 24 | $67.4M | $544.0M | ||
| Q2 24 | $39.5M | $102.0M | ||
| Q1 24 | $41.7M | $4.8M |
营业利润率MNRRPRX
| Q4 25 | 26.1% | 62.4% | ||
| Q3 25 | -7.0% | 70.1% | ||
| Q2 25 | 38.6% | 36.3% | ||
| Q1 25 | 22.8% | 94.0% | ||
| Q4 24 | 24.9% | 60.9% | ||
| Q3 24 | 37.1% | — | ||
| Q2 24 | 29.4% | 50.2% | ||
| Q1 24 | 28.1% | -13.0% |
净利率MNRRPRX
| Q4 25 | 18.9% | 34.4% | ||
| Q3 25 | -13.1% | 47.3% | ||
| Q2 25 | 31.1% | 5.2% | ||
| Q1 25 | 7.0% | 41.9% | ||
| Q4 24 | 15.5% | 35.1% | ||
| Q3 24 | 26.4% | 96.3% | ||
| Q2 24 | 16.5% | 19.0% | ||
| Q1 24 | 17.4% | 0.8% |
每股收益（稀释后）MNRRPRX
| Q4 25 | $0.47 | $0.49 | ||
| Q3 25 | $-0.28 | $0.67 | ||
| Q2 25 | $0.76 | $0.07 | ||
| Q1 25 | $0.14 | $0.55 | ||
| Q4 24 | $0.34 | $0.46 | ||
| Q3 24 | $0.70 | $1.21 | ||
| Q2 24 | $0.42 | $0.23 | ||
| Q1 24 | $0.44 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.6M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | — | $9.7B |
| 总资产 | $3.8B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MNRRPRX
| Q4 25 | $42.6M | $618.7M | ||
| Q3 25 | $53.6M | $938.9M | ||
| Q2 25 | $13.8M | $631.9M | ||
| Q1 25 | $7.8M | $1.1B | ||
| Q4 24 | $105.8M | $929.0M | ||
| Q3 24 | $184.5M | $950.1M | ||
| Q2 24 | $144.6M | $1.8B | ||
| Q1 24 | $151.3M | $843.0M |
总债务MNRRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益MNRRPRX
| Q4 25 | — | $9.7B | ||
| Q3 25 | — | $9.6B | ||
| Q2 25 | — | $9.5B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | — | $10.3B | ||
| Q3 24 | — | $10.3B | ||
| Q2 24 | — | $9.8B | ||
| Q1 24 | — | $9.9B |
总资产MNRRPRX
| Q4 25 | $3.8B | $19.6B | ||
| Q3 25 | $3.8B | $19.3B | ||
| Q2 25 | $2.3B | $18.3B | ||
| Q1 25 | $2.2B | $17.6B | ||
| Q4 24 | $2.3B | $18.2B | ||
| Q3 24 | $2.3B | $18.0B | ||
| Q2 24 | $2.2B | $17.7B | ||
| Q1 24 | $2.3B | $16.1B |
负债/权益比MNRRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $128.7M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.76× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MNRRPRX
| Q4 25 | $128.7M | $827.1M | ||
| Q3 25 | $105.5M | $702.6M | ||
| Q2 25 | $130.1M | $364.0M | ||
| Q1 25 | $142.5M | $596.1M | ||
| Q4 24 | $133.7M | $742.5M | ||
| Q3 24 | $110.8M | $703.6M | ||
| Q2 24 | $116.8M | $658.2M | ||
| Q1 24 | $144.0M | $664.6M |
现金转化率MNRRPRX
| Q4 25 | 1.76× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | 1.45× | 12.06× | ||
| Q1 25 | 8.97× | 2.50× | ||
| Q4 24 | 3.66× | 3.57× | ||
| Q3 24 | 1.64× | 1.29× | ||
| Q2 24 | 2.96× | 6.45× | ||
| Q1 24 | 3.45× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MNR
| Oil Gas And Natural Gas Liquids Net | $331.0M | 85% |
| Natural Gas Liquids Reserves | $44.8M | 12% |
| Natural Gas Midstream | $8.6M | 2% |
| Products | $6.3M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
